News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,311 Results
Type
Article (40881)
Company Profile (267)
Press Release (680153)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204656)
Career Advice (2022)
Deals (35532)
Drug Delivery (110)
Drug Development (81374)
Employer Resources (173)
FDA (16405)
Job Trends (14941)
News (346358)
Policy (32723)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2565)
Accelerated approval (31)
Adcomms (24)
Allergies (139)
Alliances (49575)
ALS (169)
Alzheimer's disease (1662)
Antibody-drug conjugate (ADC) (306)
Approvals (16669)
Artificial intelligence (506)
Autoimmune disease (149)
Automation (37)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (633)
Cancer (4764)
Cardiovascular disease (396)
Career advice (1707)
Career pathing (35)
CAR-T (279)
CDC (44)
Celiac Disease (2)
Cell therapy (734)
Cervical cancer (36)
Clinical research (69516)
Collaboration (1683)
Company closure (4)
Compensation (1148)
Complete response letters (53)
COVID-19 (2709)
CRISPR (87)
C-suite (825)
Cystic fibrosis (143)
Data (6178)
Decentralized trials (2)
Denatured (25)
Depression (131)
Diabetes (498)
Diagnostics (6678)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (247)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (228)
Earnings (90067)
Editorial (55)
Employer branding (21)
Employer resources (152)
Events (117216)
Executive appointments (965)
FDA (19494)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1453)
Gene editing (191)
Generative AI (43)
Gene therapy (588)
GLP-1 (964)
Government (4654)
Grass and pollen (6)
Guidances (383)
Healthcare (18868)
HIV (56)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (247)
Immuno-oncology (56)
Indications (104)
Infectious disease (2969)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (242)
Interviews (315)
IPO (16640)
IRA (49)
Job creations (3641)
Job search strategy (1427)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (545)
Leadership (30)
Legal (7948)
Liver cancer (91)
Longevity (14)
Lung cancer (644)
Lymphoma (374)
Machine learning (42)
Management (59)
Manufacturing (782)
MASH (161)
Medical device (13757)
Medtech (13809)
Mergers & acquisitions (19956)
Metabolic disorders (1259)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (311)
Neuropsychiatric disorders (86)
Neuroscience (2879)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4509)
Now hiring (65)
Obesity (591)
Opinion (257)
Ovarian cancer (165)
Pain (197)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (33)
Patents (488)
Patient recruitment (477)
Peanut (55)
People (58831)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21671)
Phase 2 (30598)
Phase 3 (22794)
Pipeline (5158)
Policy (279)
Postmarket research (2564)
Preclinical (9192)
Press Release (64)
Prostate cancer (235)
Psychedelics (47)
Radiopharmaceuticals (278)
Rare diseases (823)
Real estate (5954)
Recruiting (70)
Regulatory (24437)
Reports (51)
Research institute (2385)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (190)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3613)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (989)
Venture capital (86)
Weight loss (378)
Women's health (89)
Worklife (18)
Date
Today (138)
Last 7 days (620)
Last 30 days (2168)
Last 365 days (29849)
2026 (3040)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (306)
Arkansas (13)
Asia (39199)
Australia (6405)
California (11194)
Canada (3261)
China (1090)
Colorado (474)
Connecticut (471)
Delaware (333)
Europe (84456)
Florida (1668)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (853)
India (64)
Indiana (516)
Iowa (22)
Japan (422)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1371)
Massachusetts (8030)
Michigan (320)
Minnesota (622)
Mississippi (5)
Missouri (127)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2975)
New Mexico (28)
New York (2952)
North Carolina (1443)
North Dakota (8)
Northern California (5459)
Ohio (331)
Oklahoma (21)
Oregon (41)
Pennsylvania (2262)
Puerto Rico (23)
Rhode Island (47)
South America (1107)
South Carolina (65)
South Dakota (1)
Southern California (4357)
Tennessee (173)
Texas (1728)
United States (39695)
Utah (334)
Vermont (1)
Virginia (258)
Washington D.C. (81)
Washington State (914)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
721,311 Results for "surmodics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biocoat Announces Formation of Surmodics Services & Technologies Division Following Merger and Divestiture Transactions
December 11, 2025
·
2 min read
Press Releases
Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28
October 28, 2025
·
4 min read
Press Releases
Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3
November 4, 2025
·
5 min read
BioMidwest
Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
Surmodics, Inc. announced it has been awarded a group purchasing agreement for thrombectomy products with Premier, Inc. Effective June 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Surmodics Pounce™ and Pounce™ Venous Thrombectomy Systems.
June 10, 2024
·
4 min read
Press Releases
Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations
November 5, 2025
·
7 min read
Press Releases
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8
August 7, 2025
·
1 min read
Press Releases
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform
October 29, 2025
·
8 min read
BioMidwest
Surmodics to Participate in Upcoming Investor Conferences in March and April
Surmodics, Inc. today announced that management will participate in the following upcoming investor conferences.
February 27, 2024
·
1 min read
Press Releases
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
April 28, 2025
·
1 min read
Business
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Surmodics, Inc today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, May 1.
April 19, 2024
·
2 min read
1 of 72,132
Next
